CSL Limited

The principal activities of the consolidated entity are the research, development, manufacture, marketing, and distribution of biopharmaceutical and allied products.

Australian Securities Exchange: CSL

Comparative Analysis

Income Statement

($'M) $ Change % Change
Revenue 9,150.8 10,310.0 1,159.2 12.7
Less: Cost of Goods Sold -3,924.4 -4,466.7 -542.3 13.8
Gross Profit 13,075.2 14,776.7 1,701.5 13.0
Less: Operating Costs -2,509.9 -2,713.3 -203.4 8.1
Operating Profit 15,585.1 17,490.0 1,904.9 12.2
Less: Financing Costs -143.8 -166.9 -23.1 16.1
Earnings Before Tax 15,728.9 17,656.9 1,928.0 12.3
Less: Income Tax -470.2 -588.1 -117.9 25.1
Net Profit 16,199.1 18,245.0 2,045.9 12.6

Company vs Index

Company vs Sector

Company vs Industry Group

Balance Sheet

($'M) $ Change % Change
Current Assets 6,446.2 7,389.7 943.5 14.6
Non Current Assets 9,018.5 10,767.2 1,748.7 19.4
Assets 15,464.7 18,156.9 2,692.2 17.4
Current Liabilities 2,141.5 3,103.6 962.1 44.9
Non Current Liabilities 6,795.7 6,672.0 -123.7 -1.8
Liabilities 8,937.2 9,775.6 838.4 9.4
Equity 6,527.5 8,381.3 1,853.8 28.4

Company vs Index

Company vs Sector

Company vs Industry Group

Cash Flow Statement

($'M) $ Change % Change
Cash Flow from Operating Activities 2,488.3 3,621.9 1,133.6 45.6
Cash Flow from Financing Activities -642.7 -1,401.8 -759.1 118.1
Cash Flow from Investing Activities -1,366.7 -1,673.2 -306.5 22.4
Net Cash Flow 478.9 546.9 68.0 14.2
Foreign Exchange Fluctuations 14.6 31.9 17.3 118.5
Cash at the Beginning of the Period 657.8 1,151.3 493.5 75.0
Cash at the End of the Period 1,151.3 1,730.1 578.8 50.3

Company vs Index

Company vs Sector

Company vs Industry Group

Ratio Analysis

Profitability

Change
Gross Profit Margin 142.9% 143.3% 0.4%
Operating Profit Margin 170.3% 169.6% -0.7%
Net Profit Margin 177.0% 177.0% -0.1%

Company vs Index

Company vs Sector

Company vs Industry Group

Management Effectiveness

Change
Return on Assets 104.7% 100.5% -4.3%
Return on Equity 248.2% 217.7% -30.5%
Current Ratio 3.0 2.4 -0.6
Debt to Equity Ratio 1.4 1.2 -0.2

Company vs Index

Company vs Sector

Company vs Industry Group

Valuation

Change  
Share Price ($) 287.00 285.19 -1.81 -0.6%
Ordinary Shares 454,048,707 455,128,517 1,079,810 0.2%
Market Capitalisation ($) 130,311,978,909 129,798,101,763 -513,877,146 -0.4%
Revenue per Share ($) 20.15 22.65 2.50 12.4%
Earnings per Share ($) 35.68 40.09 4.41 12.4%
Equity per Share ($) 14.38 18.42 4.04 28.1%
Dividends per Share ($) 1.94 2.10 0.16 8.2%
Dividend Yield 0.7% 0.7% 0.1%  
Price to Sales Ratio 14.2 12.6 -1.7 -11.6%
Price to Earnings Ratio 8.0 7.1 -0.9 -11.6%
Price to Book Ratio 20.0 15.5 -4.5 -22.4%

Company vs Index

Company vs Sector

Company vs Industry Group